Fatty acids non-esterified

The albumin and non-esterified fatty acid complexes (99 1) constitute only about 5% of all plasma lipoprotein. 

Only a very small proportion of the fatty acids are present in the free, unester-ified form and the vast majority are components of other lipids. Nevertheless it is important to be able to measure and identify the free fatty acids present in either form and for this they must be first extracted into an organic solvent and then usually converted to their methyl ester. The simplest method of methyla-tion, which is applicable to both esterified and non-esterified fatty acids, is to heat the lipid sample for 2 h under a current of nitrogen at 80-90°C with 4% sulphuric acid in methanol. After cooling and the addition of water, the resulting methyl esters are extracted several times into hexane and the combined extracts are dried over sodium carbonate and anhydrous sodium sulphate. The solvent fraction is then reduced in volume by a stream of nitrogen. 

Plasma non-esterified fatty acids (NEFA) were elevated by infusion of a lipid emulsion and heparin with a constant rate of 1.5 ml/min (lipid emulsion, protocols [1] and [3]) and 0.4 lU/kg per minute (heparin). In protocol [2] a solution of 0.9% saline was infused as a control for the lipid emulsion. 

General physiological roles for fatty acids in cellular lipids are caloric storage, membrane fluidity, and prostaglandin precursors. The first of these mainly involved the formation and hydrolysis of triacyl glycerols, transport and activation of non-esterified fatty acids, and other steps leading to energy conversion (110). The second role primarily involves activation and incorporation into 1- and 2- positions of different phospholipids which form a major part of membranes. The third role is linked to the requirement for certain unsaturated fatty acids in the diets of most animals (110). 

Lipids are of special concern in comparing plastic metabolism between the two groups of fish. Triacyl-glycerols, cholesterol ethers and non-esterified fatty acids, which are the direct sources of energy, have already been discussed in the previous section. We now turn to phospholipids and cholesterol, which are essential to the structure of cell membranes, and to polyunsaturated fatty acids, which determine to a large extent the functional activity of these membranes. 

Figure 26 Dynamics of lipid fractions in round goby, from the Sea of Azov, during embryonic development. (After Chepumov and Tkachenko, 1983.) Columns at each stage, left to right Phospholipids, cholesterols, non-esterified fatty acids, triacyl-glycerols line curve, total lipids.

Figure 53 Seasonal changes in the lipid fractions of the white muscle of anchovy O, triacyl-glycerols , phospholipids A, non-esterified fatty acids.

Circulating glucose and insulin levels are the key values for a diagnosis of type II diabetes. Obesity and elevated levels of non-esterified fatty acids (NEFA) are known to cause insulin resistance and diabetes. Comorbidity of T2DM and dyslipidemia are common in animal models and in clinical populations and therefore, cholesterol, triglycerides, inflammation markers, and blood pressure are often measured within the same experiments. However, for the purpose of this chapter, we will cover only values directly linked to T2DM. 

Free fatty acids are elevated in the plasma of obese patients and are known to cause muscle and liver insulin resistance. The Wako HR series NEFA-HR(2) is an in vitro enzymatic colorimetric method assay for the quantitative determination of non-esterified fatty acids (NEFA) in serum. Perform the assay on serum collected from mice fasted for a period greater than 4 h, but less than 16 h. Perform the test on samples immediately after collection, without freezing. Also note that hemolysis in the serum samples may interfere with the assay. 

More than 95% of Ci8 and longer-chain fatty acids in milk fat are derived from the blood TAG-rich lipoproteins. Non-esterified fatty acids are... 

NEFA Non-esterified Fatty Acids (also called free fatty acids, FFA)... 

GH administered to hypophysectomized rats in vivo causes a drop in the level of plasma non-esterified fatty acids (NEFA), followed by a prolonged increase in this level [89]. This appears to be due to increased utilization of lipids - increased uptake of NEFA by muscle preceding increased output by adipose tissue. As a consequence GH diverts the energy metabolism of the organism from carbohydrate utilization to lipid utilization, and acts to oppose the effects of insulin. Actions of GH on lipid metabolism are particularly marked in man, where GH levels become elevated on fasting and presumably serve to help stimulate the increased lipid utilization seen in this condition. In contrast, in the rat, GH levels fall on fasting. 

It was shown by Balasubramanian et al. [51] that mixtures of non-esterified fatty acids, isolated from intestinal brush-order cells, were powerful inhibitors of lipid peroxidation apparently quite substantial amounts of free fatty acids are present in these cells. Subsequent work showed that the principal active constituent of this lipid mixture was oleic acid [52], and that it is highly likely that the mode of action of inhibition by the monounsaturated fatty acids of lipid peroxidation involves complexing transition metals which are therefore not available to act as catalysts in the peroxidation mechanism [53]. 

MSH-R, melanoc5de stimulating hormone receptor MTP, microsomal triglyceride transfer protein NEFA, non-esterified fatty acids NO, nitric oxide NPY, neuropeptide Y... 

Uncoupling results in dissipation of the respiratory chain-produced ApH+ due to increased conductance of the inner mitochondrial membrane. Thus energy released by respiration is immediately dissipated as heat without formation and hydrolysis of ATP. Non-esterified fatty acids proved to be compounds mediating the thermoregulatory uncoupling. They operate as protonophorous uncouplers with the help of special uncoupling proteins (UCPs) or some mitochondrial antiporters i.e. the ATP/ADP antiporter and aspartate/glutamate antiporter [1-5]. 

Conquer, J.A. and Holub, B.J. (1998) Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. J. Lipid Res. 39 286-292. 

K,N. Frayn, Non-esterified fatty acid metabolism and postprandial lipaemia, Atherosclerosis, 1998, 141, 41-46. 

K.N. Frayn, C M. Williams, and P. Ar-NER, Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases , Clin. Sci., 1996, 90, 243-253. 

H.Y. Yu, T. Inoguchi, M. Kakimoto, N. Nakashima, M. Imamura, T. Hashimoto, F. Umeda, and H. Nawata, Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase C activity in cultured aortic smooth muscle cells, Diabetologia, 2001, 44, 614—620. 

M. Rosenstock, A. S. Greenberg, and A. Rudich, Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-a in 3T3-L1 adipocytes, Diabetologia, 2001, 44, 55-62. 

---